Skip to main content
Clinical Trials/ISRCTN03784241
ISRCTN03784241
Completed
N/A

Genetically determined brain abnormalities in Down's syndrome - towards a treatment: a randomised, single-blind, placebo-controlled trial of lithium carbonate in Down's syndrome

King's College London (UK)0 sites19 target enrollmentAugust 19, 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Down's syndrome
Sponsor
King's College London (UK)
Enrollment
19
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 19, 2009
End Date
December 31, 2011
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
King's College London (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Individuals with Down's syndrome
  • 2\. Over the age of 18 years, either sex
  • 3\. Able to provide informed consent for themselves or have a representative to provide proxy consent on their behalf if they lack capacity
  • 4\. Able to communicate with the investigator and to comply with requirements of the study
  • 5\. Has carer support

Exclusion Criteria

  • 1\. Individuals with contraindications to lithium treatment
  • 2\. Individuals with contraindications to undergoing a magnetic resonance scan
  • 3\. Non\-compliance with taking of the tablets between baseline and the final assessment
  • 4\. Treatment with lithium within the last 6 months
  • 5\. Evidence of dementia
  • 6\. Evidence of renal, thyroid or cardiac disease that would contraindicate taking lithium
  • 7\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials